# Safety and Efficacy of Trastuzumab BS

> **NCT04181333** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 8 (actual)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** TRASTUZUMAB BS

## Key facts

- **NCT ID:** NCT04181333
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-09
- **Primary completion:** 2025-03-27
- **Final completion:** 2025-03-27
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04181333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04181333, "Safety and Efficacy of Trastuzumab BS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04181333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*